✦ LIBER ✦
Farnesoid X receptor (FXR) status complements the evaluation of estrogen receptor alpha (ER) in breast cancer (BC) patients and predicts benefit from tamoxifen
✍ Scribed by F. Journe; V. Durbecq; B. Haibe-Kains; C. Chaboteaux; G. Rouas; G. Laurent; D. Larsimont; M. Piccart; J.J. Body; C. Sotiriou
- Book ID
- 119598028
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 56 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.